Taming the dragon: genomic biomarkers to individualize the treatment of cancer

被引:0
|
作者
Ian J Majewski
René Bernards
机构
[1] Centre for Biomedical Genetics and Cancer Genomics Centre,Division of Molecular Carcinogenesis
[2] The Netherlands Cancer Institute,undefined
来源
Nature Medicine | 2011年 / 17卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The gradual shift from cytotoxic drugs to highly selective, targeted therapeutic agents for cancer requires a parallel effort to characterize cancers at the molecular level to guide the choice of therapy for the individual patient. Here we review the genomic technologies that can be used to develop these drug response indicators, or biomarkers. We also discuss hurdles in their development and the implementation of biomarkers in clinical practice.
引用
收藏
页码:304 / 312
页数:8
相关论文
共 50 条
  • [41] CAN PET IMAGING HELP INDIVIDUALIZE THE TREATMENT OF COLORECTAL CANCER PATIENTS?
    Hendlisz, A.
    ANNALS OF ONCOLOGY, 2012, 23 : 63 - 63
  • [42] Taming the dragon: stock exchange comment letters and earnings volatility
    Yao, Yao
    Li, Bin
    Qin, Bo
    Yang, Xing
    ACCOUNTING AND BUSINESS RESEARCH, 2024,
  • [43] International aid and China's environment: Taming the yellow dragon
    Shapiro, Judith
    CHINA JOURNAL, 2007, 57 : 239 - 241
  • [44] Taming the Dragon Effective Use of Dragon Naturally Speaking Speech Recognition Software as an Avenue to Universal Access
    Altman, James
    WRITING & PEDAGOGY, 2013, 5 (02): : 333 - 348
  • [45] A comprehensive review of genomic landscape, biomarkers and treatment sequencing in castration-resistant prostate cancer
    Seisen, Thomas
    Roupret, Morgan
    Gomez, Florie
    Malouf, Gabriel G.
    Shariat, Shahrokh F.
    Peyronnet, Benoit
    Spano, Jean-Philippe
    Cancel-Tassin, Geraldine
    Cussenot, Olivier
    CANCER TREATMENT REVIEWS, 2016, 48 : 25 - 33
  • [46] Is it possible to individualize prescription of medical treatment in colorectal cancer? The clinician point of view
    Ducreux, Michel
    Boige, Valerie
    Malka, David
    Laurent-Puig, Pierre
    BULLETIN DU CANCER, 2008, 95 (10) : 931 - 934
  • [48] Use of biomarkers to individualize antimicrobial therapy duration: a narrative review
    Scott, Jake
    Deresinski, Stan
    CLINICAL MICROBIOLOGY AND INFECTION, 2023, 29 (02) : 160 - 164
  • [49] Echocardiography to Individualize Treatment for Hypertrophic Cardiomyopathy
    Sherrid, Mark V.
    Arabadjian, Milla
    PROGRESS IN CARDIOVASCULAR DISEASES, 2012, 54 (06) : 461 - 476
  • [50] GENOMIC AND IMMUNOLOGICAL BIOMARKERS FOR PREDICTING TREATMENT OUTCOME IN DEPRESSION
    Ising, Marcus
    Belcredi, Petra
    Lucae, Susanne
    Tontsch, Alina
    Namendorf, Christian
    Uhr, Manfred
    Holsboer, Florian
    Rex-Haffner, Monika
    Simulionyte, Egle
    Hebib, Sandi
    Gruber, Oliver
    Behler, Nora
    Nenov-Matt, Tabea
    Schuele, Cornelius
    Manook, Andre
    Heckel, Barbara
    Baghai, Thomas
    Rupprecht, Rainer
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2025, 28 : i314 - i314